How pain arises in Parkinson's disease?

European Journal of Neurology

Volumn 20, Issue 12, 2013, Pages 1517-1523

  Defazio, G ^a   Tinazzi, M ^b   Berardelli, A ^c  

^a UNIVERSITY OF BARI   (Italy)

^b UNIVERSITY OF VERONA   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Pain; Parkinson's disease; Pathophysiology

Indexed keywords

BRADYKINESIA; CONTRACTURE; DYSTONIA; GENETIC SUSCEPTIBILITY; HUMAN; PAIN ASSESSMENT; PARKINSON DISEASE; PRIORITY JOURNAL; REVIEW; RIGIDITY;

PAIN; PARKINSON'S DISEASE; PATHOPHYSIOLOGY;

HUMANS; PAIN; PARKINSON DISEASE;

EID: 84887404219     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/ene.12260     Document Type: Review

References (43)

1. Barone P, Antonini A, Colosimo C, et al. The PRIAMO STUDY: a multi center assessment of non motor symptoms and their impact on quality of life in Parkinson's disease. Mov Disord 2009; 24: 1641-1649.
2. Politis M, Wu K, Molloy S, Bain P, Chaudhuri KR, Piccini P. Parkinson's disease symptoms: the patient's perspective. Mov Disord 2010; 25: 1646-1651.
3. Gallagher DA, Lees AJ, Schrag A. What are the most important nonmotor symptoms in patients with Parkinson's disease and are we missing them? Mov Disord 2010; 25: 2493-2500.
4. Ford B. Pain in Parkinson's disease. Mov Disord 2010; 25(Suppl. 1): S98-S103.
5. Sigwald J, Solignac J. Manifestations douloureuses de la maladie de Parkinson et paresthesies provoquees par les neuroleptiques. Sem Hop Paris 1960; 41: 2222-2225.
6. Snider SR, Fahn S, Isgreen WP, Cote LJ. Primary sensory symptoms in parkinsonism. Neurology 1976; 26: 423-429.
7. Quinn NP, Koller WC, Lang AE, et al. Pain in Parkinson's disease. Lancet 1986; 1: 1366-1369.
8. Ford B, Louis ED, Greene P, Fahn S. Oral and genital pain syndromes in Parkinson's disease. Mov Disord 1996; 11: 421-426.
9. Beiske AG, Loge JH, Rønningen A, Svensson E. Pain in Parkinson's disease: prevalence and characteristics. Pain 2009; 141: 173-177.
10. Broetz D, Eichner M, Gasser T, Weller M, Steinbach JP. Radicular and nonradicular back pain in Parkinson's disease: a controlled study. Mov Disord 2007; 22: 853-856.
11. Defazio G, Berardelli A, Fabbrini G, et al. Pain as a nonmotor symptom of Parkinson's disease. Arch Neurol 2008; 65: 1191-1194.
12. Ehrt U, Larsen JP, Aarsland D. Pain and its relationship to depression in Parkinson disease. Am J Geriatr Psychiatry 2009; 17: 269-275.
13. Madden MB, Hall DA. Shoulder pain in Parkinson's disease: a case-control study. Mov Disord 2010; 25: 1105-1106.
14. Zambito Marsala S, Tinazzi M, Vitaliani R, et al. Spontaneous pain, pain threshold, and pain tolerance in Parkinson's disease. J Neurol 2011; 258: 627-633.
15. Tinazzi M, Del Vesco C, Fincati E. Pain and motor complications in Parkinson's disease. J Neurol Neurosurg Psychiatry 2006; 77: 822-825.
16. Nègre-Pagès L, Regragui W, Bouhassira D, et al. Chronic pain in Parkinson's disease: the cross sectional French DoPaMiP survey. Mov Disord 2008; 23: 1361-1369.
17. Vela L, Facca A, Lyons KE, Lieberman AN. Pain and Parkinson's disease. Mov Disord 2002; 17(Suppl. 5): S154-S155.
18. Goetz CG, Tanner CM, Lewy M, et al. Pain in Parkinson's disease. Mov Disord 1986; 1: 45-49.
19. McNamara P, Stavitsky K, Harris E, et al. Mood, side of motor symptom onset and pain complaints in Parkinson's disease. Int J Geriatr Psychiatry 2010; 25: 519-524.
20. Greenbaum L, Tegeder I, Barhum Y, et al. Contribution of genetic variants to pain susceptibility in Parkinson disease. Eur J Pain 2012; 9: 1243-1250.
21. Nebe A, Ebersbach G. Pain intensity on and off levodopa in patients with Parkinson's disease. Mov Disord 2009; 24: 1233-1237.
22. Lim SY, Farrell MJ, Evans AH. Parkinson's disease and pain - nondopaminergic mechanisms are likely to be important too. Mov Disord 2011; 26: 1353-1354.
23. Lee MA, Walker RW, Hildreth TJ, Prentice WM. A survey of pain in idiopathic Parkinson's disease. J Pain Symptom Manage 2006; 32: 462-469.
24. Wasner G, Deuschl G. Pains in Parkinson disease - many syndromes under one umbrella. Nat Rev Neurol 2012; 8: 284-294.
25. Wood PB. Role of central dopamine in pain and analgesia. Expert Rev Neurother 2008; 8: 781-797.
26. Potvin S, Grugnon S, Marchand S. Human evidence of supra-spinal modulating role of dopamine in pain perception. Synapse 2009; 63: 309-402.
27. Gerdelat-Mas A, Simonetta-Moreau M, Thalamas C, et al. Levodopa raises objective pain threshold in Parkinson's disease: a RIII reflex study. J Neurol Neurosurg Psychiatry 2007; 78: 1140-1142.
28. Perrotta A, Sandrini G, Serrao M, et al. Facilitated temporal summation of pain at spinal level in Parkinson's disease. Mov Disord 2011; 26: 442-448.
29. Mylius V, Engau I, Teepker M, et al. Pain sensitivity and descending inhibition of pain in Parkinson's disease. J Neurol Neurosurg Psychiatry 2009; 80: 24-28.
30. Brefel-Courbon C, Payoux P, Thalama C, et al. Effect of levodopa on pain threshold in Parkinson's disease: a clinical and positron emission tomography study. Mov Disord 2005; 20: 1557-1563.
31. Brefel-Courbon C, Ory-Magne F, Thalamas C, Payoux P, Rascol O. Nociceptive brain activation in patients with neuropathic pain related to Parkinson's disease. Parkinsonism Relat Disord 2013; 19: 548-552.
32. Djaldetti R, Shifrin A, Rogowski Z, et al. Quantitative measurement of pain sensation in patients with Parkinson disease. Neurology 2004; 62: 2171-2175.
33. Schestatsky P, Kumru H, Valls-Sole J, et al. Neurophysiologic study of central pain in patients with Parkinson disease. Neurology 2007; 69: 2162-2169.
34. 2 laser evoked potentials. Mov Disord 2010; 25: 213-220.
35. Tinazzi M, Recchia S, Simonetto S, et al. Hyperalgesia and laser evoked potentials alterations in hemiparkinson: evidence for an abnormal nociceptive processing. J Neurol Sci 2009; 276: 153-158.
36. 2 laser evoked potentials. Pain 2008; 136: 117-124.
37. Dellapina E, Gerdelat-Mas A, Ory-Magne F, et al. Apomorphine effect on pain threshold in Parkinson's disease: a clinical and positron emission tomography study. Mov Disord 2011; 26: 153-157.
38. Lim SY, Farrell MJ, Gibson SJ, et al. Do dyskinesia and pain share common pathophysiological mechanisms in Parkinson's disease? Mov Disord 2008; 23: 1689-1695.
39. Mylius V, Brebbermann J, Dohmann H. Pain sensitivity and clinical progression in Parkinson's disease. Mov Disord 2011; 26: 2220-2225.
40. Valeriani M, Le Pera D, Restuccia D, et al. Segmental inhibition of cutaneous heat sensation and of laser-evoked potentials by experimental muscle pain. Neuroscience 2005; 136: 301-309.
41. Scherder E, Woolters E, Polman C, et al. Pain in Parkinson's disease and multiple sclerosis: its relation to medial and lateral pain systems. Neurosci Biobehav Rev 2005; 29: 1047-1056.
42. Braak H, Del Tredici K, Rub U, et al. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 2003; 24: 197-211.
43. Djaldetti R, Yust-Katz S, Kolianov V, et al. The effect of duloxetine on primary symptoms in Parkinson's disease. Clin Neuropharmacol 2007; 30: 201-205.